FreeTheAI

Entera Bio Ltd.

ENTX · NASDAQ · USD

$2.50

−0.01 −0.40%todayNot financial advice.

ENTX Price chart 6M
Open
2.48
Day range
2.45 - 2.52
52-week range
0.9100 - 4.20
Volume
421.03K
Market cap
434.59M
P/E ratio
—
EPS
-0.35
Dividend yield
0.00%
Beta
-1.09

Performance

W

−13.49%

1M

−15.25%

3M

+47.93%

6M

+116.68%

YTD

+27.55%

Y

+32.98%

5Y

−43.95%

All

−65.75%

In the news

  1. Oct 7

    Entera Bio Appoints Former Gilead Executive Laura Hamill to Board Ahead of Phase 3 Trial

    Entera Bio Ltd. appointed former Gilead executive Laura Hamill to its board of directors as it prepares to launch a Phase 3 clinical trial for EB613.

    Company news

Embed on your site

Embed docs

Add a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.

<iframe src="https://stocks.freetheai.org/embed/NASDAQ-ENTX" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Entera Bio Ltd. (ENTX) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-ENTX">ENTX stock price</a> by FreeTheAI Stocks</p>